Cargando…
S-nitrosylated and non-nitrosylated COX2 have differential expression and distinct subcellular localization in normal and breast cancer tissue
Immunohistochemical (IHC) staining in breast cancer shows both gain and loss of COX2 expression with disease risk and progression. We investigated four common COX2 antibody clones and found high specificity for purified human COX2 for three clones; however, recognition of COX2 in cell lysates was cl...
Autores principales: | Jindal, Sonali, Pennock, Nathan D., Klug, Alex, Narasimhan, Jayasri, Calhoun, Andrea, Roberts, Michelle R., Tamimi, Rulla M., Eliassen, A. Heather, Weinmann, Sheila, Borges, Virginia F., Schedin, Pepper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686348/ https://www.ncbi.nlm.nih.gov/pubmed/33298921 http://dx.doi.org/10.1038/s41523-020-00204-6 |
Ejemplares similares
-
Characterization of weaning-induced breast involution in women: implications for young women’s breast cancer
por: Jindal, Sonali, et al.
Publicado: (2020) -
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
por: Jindal, Sonali, et al.
Publicado: (2021) -
Associations of aspirin and other anti-inflammatory medications with breast cancer risk by the status of COX-2 expression
por: Yaghjyan, Lusine, et al.
Publicado: (2022) -
Loss of myoepithelial calponin‐1 characterizes high‐risk ductal carcinoma in situ cases, which are further stratified by T cell composition
por: Mitchell, Elizabeth, et al.
Publicado: (2020) -
S-Nitrosylation of mitochondrial caspases
por: Mannick, Joan B., et al.
Publicado: (2001)